Beta Bionics, Inc. (BBNX) Net Margin (2024 - 2026)

Beta Bionics (BBNX) has 3 years of Net Margin data on file, last reported at 79.26% in Q1 2026.

• Quarterly Net Margin rose 1262.0% year-over-year to 79.26% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 60.27% (up 1024.0% YoY) and the FY2025 annual result came in at 60.6%, up 289.0% from the prior year.
• Net Margin declined to 79.26% in Q1 2026 per BBNX's latest filing, from 41.92% in the prior quarter.
• The five-year high for Net Margin was 41.92% in Q4 2025, with the low at 91.88% in Q1 2025.
• Average Net Margin over 3 years is 65.96%, with a median of 64.29% recorded in 2024.
• The widest YoY moves for Net Margin: up 1721 bps in 2025, down 2759 bps in 2025.
• Beta Bionics' Net Margin stood at 59.13% in 2024, then climbed by 29 bps to 41.92% in 2025, then sank by 89 bps to 79.26% in 2026.
• Business Quant data shows BBNX's Net Margin at 79.26% in Q1 2026, 41.92% in Q4 2025, and 52.14% in Q3 2025.